Increased regulatory versus effector T cell development is associated with thymus atrophy in mouse models of multiple myeloma

The Journal of Immunology : Official Journal of the American Association of Immunologists
Ayelet Laronne-Bar-OnNechama Haran-Ghera

Abstract

CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) play a central role in cancer tolerance. However, mechanisms leading to their accumulation in cancer remain unknown. Although the thymus is the main site of Treg development, thymic contribution to Treg expansion in cancer has not been directly examined. Herein, we used two murine models of multiple myeloma (MM), 5T2 MM and 5T33 MM, to examine Treg accumulation in peripheral lymphoid organs, including spleen, lymph nodes, bone marrow, and blood, and to explore thymic Treg development during malignancy. We found that peripheral ratios of suppressive-functional Tregs increased in both models of MM-inflicted mice. We found that thymic ratios of Treg development in MM increased, in strong association with thymus atrophy and altered developmental processes in the thymus. The CD4(+)CD8(+) double-positive population, normally the largest thymocyte subset, is significantly decreased, whereas the CD4(-)CD8(-) double-negative population is increased. Administration of thymocytes from MM-inflicted mice compared with control thymocytes resulted in increased progression of the disease, and this effect was shown to be mediated by Tregs in the thymus of MM-inflicted mice. Our data suggest that ...Continue Reading

References

Jan 1, 1994·European Journal of Immunology·D BrändleH Pircher
Dec 22, 1999·The Journal of Immunology : Official Journal of the American Association of Immunologists·A M Thornton, E M Shevach
May 23, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B AdkinsD M Lopez
Jun 3, 2000·Annual Review of Immunology·E M Shevach
Jul 24, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C A Piccirillo, E M Shevach
Aug 7, 2001·Seminars in Hematology·N S Callander, G D Roodman
Aug 24, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Udaya K LiyanageDavid C Linehan
Dec 5, 2002·Journal of Mammary Gland Biology and Neoplasia·Diana M LopezBecky Adkins
Feb 28, 2003·Hematological Oncology·M RaitakariD E Joshua
Apr 22, 2003·Nature Medicine·Tyler J CurielWeiping Zou
Jun 24, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Melissa A LermanAndrew J Caton
Jul 9, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jonathan KipnisMichal Schwartz
Sep 24, 2004·The Journal of Experimental Medicine·Mary Jo TurkAlan N Houghton
Mar 5, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tomás AlvaroMiguel A Piris
Mar 24, 2005·Nature Immunology·Yasmine Belkaid, Barry T Rouse
Sep 10, 2005·Blood·Rao H PrabhalaNikhil C Munshi
Feb 24, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shaoping DengJames F Markmann
Apr 14, 2006·Cancer Immunology, Immunotherapy : CII·Nicolas LarmonierEmmanuel Katsanis
May 20, 2006·Proceedings of the National Academy of Sciences of the United States of America·Julie CabarrocasRoland S Liblau
Jun 27, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Howard S Yeh, James R Berenson
Jun 27, 2006·Journal of Immunotherapy·Udaya K LiyanageDavid C Linehan
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G JarnickiKingston H G Mills
Jul 25, 2006·Blood·Marc Beyer, Joachim L Schultze
Oct 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Nabil BoscoRhodri Ceredig
Dec 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gaynor J BatesAlison H Banham
Dec 1, 2006·Nature Immunology·Jeong M KimAlexander Y Rudensky
Dec 27, 2006·Nature·Daniel J PenningtonAdrian C Hayday
Mar 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Allison L BayerThomas R Malek
May 15, 2007·Blood·Evangelos TerposMeletios-Athanassios Dimopoulos
Sep 20, 2007·Leukemia·D Dingli, S J Russell
Jan 29, 2008·International Journal of Cancer. Journal International Du Cancer·Yoshiki MizukamiHideki Fujii

❮ Previous
Next ❯

Citations

Jan 7, 2011·Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society·Dov Zipori
Jun 8, 2013·Expert Opinion on Biological Therapy·Julia SchülerMonika Engelhardt
Dec 17, 2014·Immunological Reviews·Yawara KawanoIrene M Ghobrial
Aug 3, 2016·Scientific Reports·Naamit Deshet-UngerDrorit Neumann
May 17, 2019·Journal of Oncology·Rachel E CookeDavid Ritchie
Jul 12, 2014·BioMed Research International·Alessandra RomanoFrancesco Di Raimondo
Aug 20, 2010·Cancer Prevention Research·Amir SharabiNechama Haran-Ghera
Nov 22, 2008·Journal of Autoimmunity·Brian J ScaglioneElizabeth S Raveche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

B cells: Gene Expression

B lymphocytes are white blood cells that play a role in the adaptive immune system by secreting antibodies. Here is the latest research on gene expression in B cells.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis